ARMP
Price:
$2.33
Market Cap:
$84.31M
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.[Read more]
Industry
Biotechnology
IPO Date
1994-05-20
Stock Exchange
AMEX
Ticker
ARMP
According to Armata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.25. This represents a change of 408.39% compared to the average of -0.25 of the last 4 quarters.
The mean historical PE Ratio of Armata Pharmaceuticals, Inc. over the last ten years is -5.32. The current -1.25 PE Ratio has changed 2.25% with respect to the historical average. Over the past ten years (40 quarters), ARMP's PE Ratio was at its highest in in the December 2014 quarter at 27.67. The PE Ratio was at its lowest in in the September 2018 quarter at -9.94.
Average
-5.32
Median
-1.24
Minimum
-41.74
Maximum
1.66
Discovering the peaks and valleys of Armata Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 311.80%
Maximum Annual PE Ratio = 1.66
Minimum Annual Increase = -2611.59%
Minimum Annual PE Ratio = -41.74
Year | PE Ratio | Change |
---|---|---|
2023 | -1.69 | 46.85% |
2022 | -1.15 | -79.74% |
2021 | -5.69 | 164.90% |
2020 | -2.15 | 60.61% |
2019 | -1.34 | 311.80% |
2018 | -0.32 | -35.39% |
2017 | -0.50 | 118.68% |
2016 | -0.23 | -99.45% |
2015 | -41.74 | -2611.59% |
2014 | 1.66 | -291.83% |
The current PE Ratio of Armata Pharmaceuticals, Inc. (ARMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.84
5-year avg
-2.40
10-year avg
-5.32
Armata Pharmaceuticals, Inc.’s PE Ratio is less than Aravive, Inc. (-0.04), less than Aridis Pharmaceuticals, Inc. (0.01), greater than Anixa Biosciences, Inc. (-8.32), less than BiomX Inc. (-0.44), greater than Alpine Immune Sciences, Inc. (-112.94),
Company | PE Ratio | Market cap |
---|---|---|
-0.04 | $2.95M | |
0.01 | $44.57K | |
-8.32 | $102.74M | |
-0.44 | $21.30M | |
-112.94 | $4.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Armata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Armata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Armata Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Armata Pharmaceuticals, Inc. (ARMP)?
What is the highest PE Ratio for Armata Pharmaceuticals, Inc. (ARMP)?
What is the 3-year average PE Ratio for Armata Pharmaceuticals, Inc. (ARMP)?
What is the 5-year average PE Ratio for Armata Pharmaceuticals, Inc. (ARMP)?
How does the current PE Ratio for Armata Pharmaceuticals, Inc. (ARMP) compare to its historical average?